Search

everythinglearnresearchcommunity

for

Search:↓

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Aged individuals heal wounds less effectively due to specific immune cell issues.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Homeopathic treatment can help manage alopecia areata in children.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

More research is needed to understand and manage rheumatoid arthritis better.

Targeting specific cell interactions may help treat skin fibrosis.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Genetics influence opioid addiction risk, diet affects COVID-19 severity, Aerva lanata may harm kidneys, some plants fight fungi and cancer, and nursing students need better contraceptive knowledge.

Blocking LFA-1 prevents hair loss in mice.

Abatacept may help some people with alopecia areata regrow hair.

Targeting Vδ1+T-cells may help treat alopecia areata.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Hair follicles prevent NK cell attacks to avoid hair loss.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

ILC1-like cells can independently cause alopecia areata.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Activating Tgr5 may help treat hair loss and bone loss.